Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 15:38:59 UTC |
---|
Update Date | 2021-09-26 23:10:56 UTC |
---|
HMDB ID | HMDB0255802 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
---|
Description | 1-[5-(hydroxymethyl)oxolan-2-yl]-4-imino-1,4-dihydropyrimidin-2-ol belongs to the class of organic compounds known as pyrimidine 2',3'-dideoxyribonucleosides. Pyrimidine 2',3'-dideoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at positions 2 and 3. Based on a literature review very few articles have been published on 1-[5-(hydroxymethyl)oxolan-2-yl]-4-imino-1,4-dihydropyrimidin-2-ol. This compound has been identified in human blood as reported by (PMID: 31557052 ). 4-amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | NC1=NC(=O)N(C=C1)C1CCC(CO)O1 InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14) |
---|
Synonyms | Value | Source |
---|
2',3'-Dideoxycytidine | MeSH | HIVID roche | MeSH | 2',3' Dideoxycytidine | MeSH | Hivid | MeSH | Zalcitabine | MeSH | Dideoxycytidine | MeSH | DDC (Antiviral) | MeSH |
|
---|
Chemical Formula | C9H13N3O3 |
---|
Average Molecular Weight | 211.221 |
---|
Monoisotopic Molecular Weight | 211.095691291 |
---|
IUPAC Name | 4-amino-1-[5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one |
---|
Traditional Name | cytidine, 2',3'-dideoxy- |
---|
CAS Registry Number | Not Available |
---|
SMILES | NC1=NC(=O)N(C=C1)C1CCC(CO)O1 |
---|
InChI Identifier | InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14) |
---|
InChI Key | WREGKURFCTUGRC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrimidine 2',3'-dideoxyribonucleosides. Pyrimidine 2',3'-dideoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at positions 2 and 3. |
---|
Kingdom | Organic compounds |
---|
Super Class | Nucleosides, nucleotides, and analogues |
---|
Class | Pyrimidine nucleosides |
---|
Sub Class | Pyrimidine 2',3'-dideoxyribonucleosides |
---|
Direct Parent | Pyrimidine 2',3'-dideoxyribonucleosides |
---|
Alternative Parents | |
---|
Substituents | - Pyrimidine 2',3'-dideoxyribonucleoside
- Aminopyrimidine
- Pyrimidone
- Hydropyrimidine
- Pyrimidine
- Imidolactam
- Heteroaromatic compound
- Tetrahydrofuran
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Primary amine
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Alcohol
- Amine
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TMS,isomer #1 | C[Si](C)(C)NC1=NC(=O)N(C2CCC(CO[Si](C)(C)C)O2)C=C1 | 2222.9 | Semi standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TMS,isomer #1 | C[Si](C)(C)NC1=NC(=O)N(C2CCC(CO[Si](C)(C)C)O2)C=C1 | 2284.9 | Standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TMS,isomer #1 | C[Si](C)(C)NC1=NC(=O)N(C2CCC(CO[Si](C)(C)C)O2)C=C1 | 2924.0 | Standard polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TMS,isomer #2 | C[Si](C)(C)N(C1=NC(=O)N(C2CCC(CO)O2)C=C1)[Si](C)(C)C | 2229.3 | Semi standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TMS,isomer #2 | C[Si](C)(C)N(C1=NC(=O)N(C2CCC(CO)O2)C=C1)[Si](C)(C)C | 2368.7 | Standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TMS,isomer #2 | C[Si](C)(C)N(C1=NC(=O)N(C2CCC(CO)O2)C=C1)[Si](C)(C)C | 2985.5 | Standard polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,3TMS,isomer #1 | C[Si](C)(C)OCC1CCC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)O1 | 2212.0 | Semi standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,3TMS,isomer #1 | C[Si](C)(C)OCC1CCC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)O1 | 2380.7 | Standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,3TMS,isomer #1 | C[Si](C)(C)OCC1CCC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)O1 | 2618.5 | Standard polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CCC(CO[Si](C)(C)C(C)(C)C)O2)C=C1 | 2670.5 | Semi standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CCC(CO[Si](C)(C)C(C)(C)C)O2)C=C1 | 2712.3 | Standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC(=O)N(C2CCC(CO[Si](C)(C)C(C)(C)C)O2)C=C1 | 3030.4 | Standard polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)N(C2CCC(CO)O2)C=C1)[Si](C)(C)C(C)(C)C | 2665.9 | Semi standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)N(C2CCC(CO)O2)C=C1)[Si](C)(C)C(C)(C)C | 2808.3 | Standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C1=NC(=O)N(C2CCC(CO)O2)C=C1)[Si](C)(C)C(C)(C)C | 3030.5 | Standard polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC1CCC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)O1 | 2857.5 | Semi standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC1CCC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)O1 | 3012.9 | Standard non polar | 33892256 | 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC1CCC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)O1 | 2875.1 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one GC-MS (Non-derivatized) - 70eV, Positive | splash10-005c-9600000000-2b4de4867a39d5e3055b | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 5516 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5718 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|